Recent Posts
- African Scientist Wins Award For HIV And TB Co-infection Research
- Federal Officials To Study New Strategy To Boost HIV Testing, Treatment
- Yale Physicians Receive $4.1 Million Grant To Study New Treatment For Alcohol-Dependent HIV-Positive Inmates Transitioning Back Into Society
- Cell Phones Become Handheld Tools For Global Development
- The Unintentional Punishment: Time In Prison Should Not Lead To Infection With HIV Or Tuberculosis
Random Posts
- Also In Global Health News: Uganda ARVs; Malaria In Yemen; Seasonal Hunger; Zimbabwe Maternal Deaths; Nigeria Polio Campaign
- Secretary Of State Backs MS Society Work Retention Project
- Obama Proposes $63B Global Health Initiative Over Six Years
- Northeast Colorado Conference Discusses HIV/AIDS Needs Assessment Findings
- Global Fund Director Says G20 Can Become Donor Nations
- Grenadian Prime Minister Calls For Continued Investment In Caribbean HIV/AIDS Programs
- New Electron Microscopy Images Reveal The Assembly Of HIV
- Boston Arm Of Multi-City Study To Focus On Sexual Health, HIV Risk Among Black Gay, Bisexual Men
- Outstanding Minority Physicians Receive Awards Dedicated To HIV Medicine
- Chicago Study Looks At HIV Among Gay Men, Finds Many Unaware Of Status
Prescription AIDS Drugs
Contact Us
Yale Physicians Receive $4.1 Million Grant To Study New Treatment For Alcohol-Dependent HIV-Positive Inmates Transitioning Back Into Society
November 05th, 2009
Two Yale School of Medicine physicians have been awarded a $4.1 million research grant from the National Institutes of Health (NIH) to study a new pharmacological treatment for newly released HIV-positive inmates with alcohol dependence who are transitioning back into the community.
The U.S. prison population is disproportionately impacted by HIV and by alcohol and drug abuse. A majority of HIV-positive inmates also have substance abuse disorders. Though many are treated successfully for both HIV and substance abuse while incarcerated, they face enormous challenges when released.
“Released HIV-positive inmates who relapse to alcohol and drug use are less likely to adhere to HIV treatment, including antiretroviral drugs, and more likely to engage in high-risk behavior,” according to Frederick L. Altice, M.D., professor at Yale School of Medicine, director of clinical and community research at the Yale AIDS Program and one of the two principal investigators.
The prestigious NIH grant is the first of its stature for Sandra Springer, M.D., assistant professor of medicine and co-principal investigator - a junior investigator whose career has already benefited from a career development award from the NIH. In the clinical trial led by Springer and Altice, 125 HIV-positive prisoners with alcohol dependence who are transitioning back into society will receive subcutaneous (depot) injections of naltrexone. Though the medication has been previously shown to benefit those with alcohol dependence, HIV-infected individuals were never previously included in clinical trials.
All subjects in the trial, whether getting naltrexone or the placebo, will receive comprehensive case-management services and 24 weeks of counseling. “This is the first time that depot naltrexone will be formally tested in HIV-infected patients,” says Springer. She adds, “We hope to learn whether a medication known to benefit those with alcohol problems will also help assist with HIV treatment and prevent a relapse to high-risk behaviors. Our study could confirm that treating one disease, alcohol dependence, can actually fight two life-threatening conditions.”
Source
Yale University
View drug information on Naltrexone Hydrochloride Tablets.
Related posts:
- Yale And University Of Malaya Join Forces To Battle HIV In Prisons In the hope of stemming one of the biggest...
- Program Once Reserved For Alabama Inmates With HIV/AIDS Expanded To All Inmates Patient / Public: Health Professional: Article Opinions: ...
- Outstanding Minority Physicians Receive Awards Dedicated To HIV Medicine Two promising young physicians have been awarded this year’s Minority...
- Scientists Receive Grant To Develop Hand-Held Self-Monitoring Test For HIV Viral Loads Scientists in the United Kingdom have received a grant worth...
- $75 Million Awarded To Charles Drew University And Three Other Historically Black Institutions The National Institutes of Health has awarded $75 million to...
Related posts brought to you by Yet Another Related Posts Plugin.
No Comments »
No comments yet.
RSS feed for comments on this post. TrackBack URL
Leave a comment
You must be logged in to post a comment.